v2.4.0.6
Condensed Consolidated Statements Of Operations (Unaudited) (USD $)
 3 Months Ended 9 Months Ended
Mar. 31, 2013
Mar. 31, 2013
Revenues    
Gross revenues $ 3,608,245 $ 5,362,057
Discounts 584,983 812,526
Revenues, net of discounts 3,023,262 4,549,531
Cost of Goods Sold    
Cost of goods sold 1,405,082 2,462,005
Gross Profit 1,618,180 2,087,526
Operating expenses:    
Research and development 13,909 36,921
Royalty expense 157,895 480,704
Professional fees 844,675 1,458,198
General and administrative expenses 962,744 2,429,374
Depreciation and amortization expense 671,709 745,885
Product development fee - related party 210,000 622,700
Total Operating Expense 2,860,932 5,773,782
Loss from operations (1,242,752) (3,686,256)
Interest expense, net 661,838 957,973
Derivative liability gain (3,646,420) (3,299,793)
Net income / (loss) 1,741,830 (1,344,436)
Net income / (loss) attributable to common shareholders $ 1,741,830 $ (1,344,436)
Net income / (loss) per share attributable to common shareholders-basic and diluted $ 0.02 $ (0.02)
Weighted average number of common shares used in computation-basic and diluted 88,307,430 87,220,064